The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
Abstract
The human adenovirus E1B gene encodes a 55-kilodalton protein that inactivates the cellular tumor suppressor protein p53. Here it is shown that a mutant adenovirus that does not express this viral protein can replicate in and lyse p53-deficient human tumor cells but not cells with functional p53. Ectopic expression of the 55-kilodalton EIB protein in the latter cells rendered them sensitive to infection with the mutant virus. Injection of the mutant virus into p53-deficient human cervical carcinomas grown in nude mice caused a significant reduction in tumor size and caused complete regression of 60 percent of the tumors. These data raise the possibility that mutant adenoviruses can be used to treat certain human tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.
Scheffner, M., Münger, K., Byrne, J. C., & Howley, P. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5523 · Cited by 849
p53 functions as a cell cycle control protein in osteosarcomas.
Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., & Vogelstein, B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772 · Cited by 772
Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein
Yew, P. R., & Berk, A. J. (1992) · Nature · doi:10.1038/357082a0 · Cited by 561
Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA
Houweling, A., Van Den Elsen, P. J., & Van Der Eb, A. J. (1980) · Virology · doi:10.1016/0042-6822(80)90054-9 · Cited by 428
Analysis of the p53 gene and its expression in human glioblastoma cells.
Meir, E. G. V., Kikuchi, T., Tada, M., Li, H., Diserens, A., Wojcik, B. E., Huang, H., Friedmann, T., de Tribolet, N., & Cavenee, W. K. (1994) · PubMed · Cited by 327
(1993) · PubMed · Cited by 323
Blockage by Adenovirus E4orf6 of Transcriptional Activation by the p53 Tumor Suppressor
Dobner, T., Horikoshi, N., Rubenwolf, S., & Shenk, T. (1996) · Science · doi:10.1126/science.272.5267.1470 · Cited by 311
Righetti, S. C., Torre, G. D., Pilotti, S., Ménard, S., Ottone, F., Colnaghi, M. I., Pierotti, M. A., Lavarino, C. E., Cornarotti, M., Oriana, S., et al. (1996) · PubMed · Cited by 276
p53 point mutation in HPV negative human cervical carcinoma cell lines.
Crook, T., Wrede, C. D., & Vousden, K. H. (1991) · PubMed · Cited by 272
Kao, C. C., Yew, P. R., & Berk, A. J. (1990) · Virology · doi:10.1016/0042-6822(90)90148-k · Cited by 202
Ruggeri, B., Zhang, S.-Y., Caamaño, J., DiRado, M., Flynn, S. D., & Klein–Szanto, A. J. (1992) · PubMed · Cited by 172
White, E. (1994) · Nature · doi:10.1038/371021a0 · Cited by 150
Adenovirus E1A targets key regulators of cell proliferation.
Dyson, N. J., & Harlow, E. (1992) · PubMed · Cited by 147
Interaction of adenoviral proteins with pRB and p53
Morán, E. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344487 · Cited by 133
Kovach, J. S., Hartmann, A., Blaszyk, H., Cunningham, J. M., Schaid, D. J., & Sommer, S. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1093 · Cited by 127
Apoptosis II: The Molecular Basis of Apoptosis in Disease
Tomei, L., & Cope, F. O. (1994) · Cited by 126
Expression and interactions of human adenovirus oncoproteins
Boulanger, P. A., & Blair, G. E. (1991) · Biochemical Journal · doi:10.1042/bj2750281 · Cited by 110
Apoptosis II The molecular basis of apoptosis in disease
Griffin, M. (1995) · Biochemical Education · doi:10.1016/0307-4412(95)90210-4 · Cited by 99
Astronomers Tame a Workhorse Laser
Watson, A. (1996) · Science · doi:10.1126/science.274.5292.1470 · Cited by 56
Analysis of viral-host protein interactions and tumorigenesis in transgenic mice.
Ta, V. D. (1994) · PubMed · Cited by 31
Cited by
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Legumes: Importance and Constraints to Greater Use
Graham, P. H., & Vance, C. P. (2003) · Plant Physiology · doi:10.1104/pp.017004 · Cited by 1,801
Oncolytic viruses: a new class of immunotherapy drugs
Kaufman, H. L., Kohlhapp, F. J., & Zloza, A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4663 · Cited by 1,642
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Current state of immunotherapy for glioblastoma
Lim, M., Xia, Y., Bettegowda, C., & Weller, M. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0003-5 · Cited by 1,365
Metadata
- Authors
- Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., & McCormick, F.
- Venue
- Science
- Published
- 1996-10-18
- Volume
- 274
- Issue
- 5286
- Pages
- 373-376
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2016080258
- Cited by
- 1,760
- References
- 22
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.